The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician's review.

Kania, Karolina; Ambrosius, Wojciech; Kozubski, Wojciech; Kalinowska-Lyszczarz, Alicja

Kania, Karolina; Ambrosius, Wojciech; Kozubski, Wojciech; Kalinowska-Lyszczarz, Alicja.

Afiliación

Kania K; Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Ambrosius W; Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Kozubski W; Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland.
Kalinowska-Lyszczarz A; Department of Neurology, Division of Neurochemistry and Neuropathology, Poznan University of Medical Sciences, Poznan, Poland.

Front Neurol ; 14: 1222574, 2023.

Article en En | MEDLINE | ID: mdl-37503514

Palabras clave

SDMT; brain atrophy; cognitive functions; disease modifying therapies; multiple sclerosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Front Neurol Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google